Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bloomfield

Showing results (321-330 of 583) with videos related to

Pageof 59
Sort By:
Leukemia & Lymphoma|August 26, 1998
Expression and function of the megakaryocyte growth and development factor receptor in acute myeloid leukemia blastsM Wetzler, S H Bernstein, H Baumann, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|February 9, 2008
Tobacco use among the Amish in Holmes County, OhioAmy K Ferketich, Mira L Katz, Ross M Kauffman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461J C Byrd, D Lawrence, D C Arthur, et al.
Leukemia & Lymphoma|April 15, 2003
Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013Richard T Silver, Bercedis L Peterson, Ted P Szatrowski, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2008
A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804Richard M Stone, Kathleen A Donohue, Wendy Stock, et al.
British Journal of Haematology|July 24, 2015
Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II studyPeter M Voorhees, Robert Z Orlowski, Flora Mulkey, et al.
Blood|March 2, 2002
Comprehensive cytogenetic and molecular genetic characterization of the TI-1 acute myeloid leukemia cell line reveals cross-contamination with K-562 cell lineLaura J Rush, Kristiina Heinonen, Krzysztof Mrózek, et al.
American Journal of Hematology|April 1, 1989
Morphologic and cytochemical characteristics of acute promyelocytic leukemiaF R Davey, R B Davis, J M MacCallum, et al.
Cancer|November 1, 1990
A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851A J Gottlieb, J R Anderson, S J Ginsberg, et al.
Blood|May 4, 2007
Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemiaMichael A Caligiuri, Roger Briesewitz, Jianhua Yu, et al.
Pageof 59

Showing results (321-330 of 583) with videos related to

Sort By:
Pageof 59
Leukemia & Lymphoma|August 26, 1998
Expression and function of the megakaryocyte growth and development factor receptor in acute myeloid leukemia blastsM Wetzler, S H Bernstein, H Baumann, et al.
The Journal of Rural Health : Official Journal of the American Rural Health Association and the National Rural Health Care Association|February 9, 2008
Tobacco use among the Amish in Holmes County, OhioAmy K Ferketich, Mira L Katz, Ross M Kauffman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 2, 1998
Patients with isolated trisomy 8 in acute myeloid leukemia are not cured with cytarabine-based chemotherapy: results from Cancer and Leukemia Group B 8461J C Byrd, D Lawrence, D C Arthur, et al.
Leukemia & Lymphoma|April 15, 2003
Treatment of the chronic phase of chronic myeloid leukemia with an intermittent schedule of recombinant interferon alfa-2b and cytarabine: results from CALGB study 9013Richard T Silver, Bercedis L Peterson, Ted P Szatrowski, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2008
A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804Richard M Stone, Kathleen A Donohue, Wendy Stock, et al.
British Journal of Haematology|July 24, 2015
Long-term outcomes for newly-diagnosed multiple myeloma patients treated with pegylated liposomal doxorubicin and bortezomib: final results of CALGB (Alliance) 10301, a multicentre phase II studyPeter M Voorhees, Robert Z Orlowski, Flora Mulkey, et al.
Blood|March 2, 2002
Comprehensive cytogenetic and molecular genetic characterization of the TI-1 acute myeloid leukemia cell line reveals cross-contamination with K-562 cell lineLaura J Rush, Kristiina Heinonen, Krzysztof Mrózek, et al.
American Journal of Hematology|April 1, 1989
Morphologic and cytochemical characteristics of acute promyelocytic leukemiaF R Davey, R B Davis, J M MacCallum, et al.
Cancer|November 1, 1990
A randomized comparison of methotrexate dose and the addition of bleomycin to CHOP therapy for diffuse large cell lymphoma and other non-Hodgkin's lymphomas. Cancer and Leukemia Group B study 7851A J Gottlieb, J R Anderson, S J Ginsberg, et al.
Blood|May 4, 2007
Novel c-CBL and CBL-b ubiquitin ligase mutations in human acute myeloid leukemiaMichael A Caligiuri, Roger Briesewitz, Jianhua Yu, et al.
Pageof 59